In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA-Reference-Cited by-同舟云学术

In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA

Published:1995-04 Issue:2 Volume:90 Page:207-214
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Mevissen Meike,Kietzmann Manfred,Löscher Wolfgang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Biological effects of electromagnetic fields;Adey;J. Cell. Bioehem.,1993

2. Extremely low frequency electromagnetic fields and cancer — the epidemiologic evidence;Bates;Environ. Health Perspect.,1991

3. A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 μT magnetic field exposure;Baum;Carcinogenesis,1995

4. A microprocedure for the measurement of 14CO2 release from 14C-carboxyl-labeled amino acids;Beaven;Anal. Biochem.,1978

5. Melatonin in oncology;Blask,1993

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study the effect of the static magnetic field on some blood parameters of male rats:In vivo;2024-01-03

2. Tempol suppresses micronuclei formation in astrocytes of newborn rats exposed to 50-Hz, 10-mT electromagnetic fields under bleomycin administration;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;2012-08

3. Expression of ornithine decarboxylase during the transport of saquinavir across the blood–brain barrier using composite polymeric nanocarriers under an electromagnetic field;Colloids and Surfaces B: Biointerfaces;2011-12

4. No Evidence of Cellular Alterations by MilliTesla-Level Static and 50 Hz Magnetic Fields onS. cerevisiae;Electromagnetic Biology and Medicine;2010-10-05

5. Exposure of MCF-7 Breast Cancer Cells to Electromagnetic Fields Up-Regulates the Plasminogen Activator System;International Journal of Gynecologic Cancer;2009-03